Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
BMC Nephrol ; 19(1): 238, 2018 09 19.
Artigo em Inglês | MEDLINE | ID: mdl-30231858

RESUMO

BACKGROUND: Liver cirrhosis is characterized by avid sodium retention where the activation of the renin angiotensin aldosterone system (RAAS) is considered to be the hallmark of the sodium retaining mechanisms. The direct effect of angiotensin II (ANGII) on the AT-1 receptor in the proximal tubules is partly responsible for the sodium retention. The aim was to estimate the natriuretic and neurohumoral effects of an ANGII receptor antagonist (losartan) in the late phase of the disease in a rat model of liver cirrhosis. METHODS: Bile duct ligated (BDL) and sham operated rats received 2 weeks of treatment with losartan 4 mg/kg/day or placebo, given by gastric gavage 5 weeks after surgery. Daily sodium and potassium intakes and renal excretions were measured. RESULTS: The renal sodium excretion decreased in the BDL animals and this was not affected by losartan treatment. At baseline the plasma renin concentration (PRC) was similar in sham and BDL animals, but increased urinary excretion of ANGII and an increase P-Aldosterone was observed in the placebo treated BDL animals. The PRC was more than 150 times higher in the losartan treated BDL animals (p < 0.001) which indicated hemodynamic impairment. CONCLUSIONS: Losartan 4 mg/kg/day did not increase renal sodium excretion in this model of liver cirrhosis, although the urinary ANGII excretion was increased. The BDL animals tolerated Losartan poorly, and the treatment induced a 150 times higher PRC.


Assuntos
Bloqueadores do Receptor Tipo 1 de Angiotensina II/farmacologia , Modelos Animais de Doenças , Cirrose Hepática/urina , Losartan/farmacologia , Sistema Renina-Angiotensina/fisiologia , Sódio/urina , Bloqueadores do Receptor Tipo 1 de Angiotensina II/uso terapêutico , Animais , Colestase/sangue , Colestase/tratamento farmacológico , Colestase/urina , Rim/efeitos dos fármacos , Rim/metabolismo , Cirrose Hepática/sangue , Cirrose Hepática/tratamento farmacológico , Losartan/uso terapêutico , Masculino , Ratos , Ratos Wistar , Sistema Renina-Angiotensina/efeitos dos fármacos , Sódio/sangue
2.
Eur J Clin Microbiol Infect Dis ; 34(10): 2017-21, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26205664

RESUMO

In Europe, infections with Puumala hantavirus cause nephropathia epidemica. Presently the risk factors predicting severe kidney damage after Puumala virus infection are not well known. The objective of the study was to investigate environmental and individual factors predicting severe kidney damage caused by serologically established Puumala infections. In a nationwide cohort study we investigated all serologically established Puumala infections in Southern Denmark from 1996 to 2012. A total of 184 patients had serologically verified Puumala virus infection. In patients with Puumala virus infections the decrease of platelet counts preceded acute kidney failure. Multivariable logistic regression demonstrated that recent activities in the forest, platelet counts, and flu-like symptoms predicted estimated glomerular filtration rates less than 30 mL/min/1.73 m(²), but not age, gender, fever, nor abdominal pain. Severe kidney damage in Puumala infections in Southern Denmark is associated with the risk of recent activities in the forest.


Assuntos
Injúria Renal Aguda/sangue , Injúria Renal Aguda/etiologia , Febre Hemorrágica com Síndrome Renal/sangue , Febre Hemorrágica com Síndrome Renal/complicações , Adulto , Estudos de Coortes , Dinamarca , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Contagem de Plaquetas , Valor Preditivo dos Testes , Virus Puumala , Fatores de Risco
3.
Acta Physiol Scand ; 184(2): 161-9, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15916676

RESUMO

AIM: In mineralocorticoid target cells 11-beta-hydroxysteroid dehydrogenase type 2 (11betaHSD2) converts glucocorticoids into non-active metabolites thereby protecting the mineralocorticoid receptor (MR) from stimulation by glucocorticoids. In nephrotic syndrome, a decreased activity of 11betaHSD2 has been suggested to allow glucocorticoids to stimulate MR, thereby contributing to sodium retention. We tested this hypothesis in the puromycin aminonucleoside model of nephrotic syndrome in rats. METHODS: Complete sodium and potassium intakes and excretions (faeces and urine) were measured in rats in metabolic cages. RNase protection assay of mRNA and Western blotting of protein were used to estimate renocortical expression of 11betaHSD2 and of the MR downstream effector serum and glucocorticoid induced kinase (SGK). In an intervention series, dexamethasone was given [10 microg (100 g bw)(-1)] to suppress endogenous glucocorticoids in the proteinuric stage during active sodium retention. RESULTS: Nephrotic rats developed proteinuria, positive sodium balance, decreased plasma aldosterone concentration, and decreased urinary Na(+)/K(+) ratio. 11betaHSD2 mRNA expression was down-regulated but protein expression was unchanged. SGK mRNA and phosphorylated SGK protein were up-regulated while total SGK protein expression was unchanged. Dexamethasone treatment, which suppressed plasma corticosterone concentration, did not correct sodium balance or fluid retention in nephrotic rats. CONCLUSION: Our results do not support the hypothesis that stimulation of the MR by endogenous glucocorticoids induces sodium and fluid retention in experimental nephrotic syndrome in rats.


Assuntos
11-beta-Hidroxiesteroide Desidrogenase Tipo 2/metabolismo , Síndrome Nefrótica/metabolismo , Sódio/metabolismo , 11-beta-Hidroxiesteroide Desidrogenase Tipo 2/análise , Aldosterona/sangue , Animais , Corticosterona/sangue , Dexametasona/farmacologia , Modelos Animais de Doenças , Regulação para Baixo/fisiologia , Fezes/química , Glucocorticoides/farmacologia , Córtex Renal/efeitos dos fármacos , Córtex Renal/metabolismo , Masculino , Síndrome Nefrótica/enzimologia , Fosforilação , Potássio/metabolismo , Potássio/urina , Proteinúria/enzimologia , Proteinúria/metabolismo , Puromicina Aminonucleosídeo , RNA Mensageiro , Ratos , Ratos Sprague-Dawley , Sódio/urina , Regulação para Cima/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...